Balázs Győrffy MD PhD DSc MAE
Balázs Győrffy MD PhD DSc MAE
Full Professor, Semmelweis University, Hungarian Academy of Sciences, member of Academia Europaea
E-mail megerősítve itt: med.semmelweis-univ.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
B Györffy, A Lanczky, AC Eklund, C Denkert, J Budczies, Q Li, Z Szallasi
Breast cancer research and treatment 123 (3), 725-731, 2010
16432010
Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer
B Gyorffy, P Surowiak, J Budczies, A Lanczky
PloS one 8 (12), e82241-e82241, 2013
7772013
Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization
J Budczies, F Klauschen, BV Sinn, B Győrffy, WD Schmitt, ...
PloS one 7 (12), e51862, 2012
6782012
Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
AM Szász, A Lánczky, Á Nagy, S Förster, K Hark, JE Green, ...
Oncotarget 7 (31), 49322, 2016
5102016
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.
B Győrffy, A Lánczky, Z Szállási
Endocrine-related cancer 19 (2), 197-208, 2012
4652012
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
A Lánczky, Á Nagy, G Bottai, G Munkácsy, A Szabó, L Santarpia, B Győrffy
Breast cancer research and treatment 160 (3), 439-446, 2016
3822016
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Á Nagy, A Lánczky, O Menyhárt, B Győrffy
Scientific reports 8 (1), 1-9, 2018
2992018
Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer
B Győrffy, P Surowiak, J Budczies, A Lánczky
PloS one 8 (12), e82241, 2013
2902013
Jetset: selecting the optimal microarray probe set to represent a gene
Q Li, NJ Birkbak, B Gyorffy, Z Szallasi, AC Eklund
BMC bioinformatics 12 (1), 1-7, 2011
2112011
Multigene prognostic tests in breast cancer: past, present, future
B Győrffy, C Hatzis, T Sanft, E Hofstatter, B Aktas, L Pusztai
Breast cancer research 17 (1), 11, 2015
2032015
Multigene prognostic tests in breast cancer: past, present, future
B Győrffy, C Hatzis, T Sanft, E Hofstatter, B Aktas, L Pusztai
Breast cancer research 17 (1), 11, 2015
2032015
Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations
B Györffy, P Surowiak, O Kiesslich, C Denkert, R Schäfer, M Dietel, ...
International journal of cancer 118 (7), 1699-1712, 2006
1842006
A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
Z Mihály, M Kormos, A Lánczky, M Dank, J Budczies, MA Szász, B Győrffy
Breast cancer research and treatment 140 (2), 219-232, 2013
1422013
Systematic evaluation of the miRNA‐ome and its downstream effects on mRNA expression identifies gastric cancer progression
O Tchernitsa, A Kasajima, R Schäfer, RJ Kuban, U Ungethüm, B Györffy, ...
The Journal of pathology 222 (3), 310-319, 2010
1412010
Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities
DC Porter, E Farmaki, S Altilia, GP Schools, DK West, M Chen, BD Chang, ...
Proceedings of the National Academy of Sciences 109 (34), 13799-13804, 2012
1372012
The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1
R Abdul-Ghani, V Serra, B Györffy, K Jürchott, A Solf, M Dietel, R Schäfer
Oncogene 25 (12), 1743-1752, 2006
1272006
Gender-specific association of vitamin D receptor polymorphism combinations with type 1 diabetes mellitus
B Györffy, B Vásárhelyi, D Krikovszky, L Madácsy, A Tordai, T Tulassay, ...
European journal of endocrinology 147 (6), 803-808, 2002
1212002
Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
L Magnani, A Stoeck, X Zhang, A Lánczky, AC Mirabella, TL Wang, ...
Proceedings of the National Academy of Sciences 110 (16), E1490-E1499, 2013
1192013
Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue–a GC-TOFMS based metabolomics study
J Budczies, C Denkert, BM Müller, SF Brockmöller, F Klauschen, B Györffy, ...
BMC genomics 13 (1), 1-11, 2012
1072012
Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1
H Zhang, SK Ramakrishnan, D Triner, B Centofanti, D Maitra, B Győrffy, ...
Science signaling 8 (397), ra98-ra98, 2015
1052015
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20